North Carolina Product Liability Lawyer Blog

After more than twenty-one years at Harris Sarratt & Hodges, LLP, I made the move to start my own law firm: Hodges Law, PLLC. I had a great run at HSH, and I learned so much about practicing law from my law partners and from staff, but it was time for this new challenge. I…

The U.S. Supreme Court has agreed to hear a case that could fundamentally reshape one of the largest mass-tort litigations in American history: the lawsuits alleging that Roundup, the widely used weed-killer, causes cancer. Roundup has been on the market since the 1970s and became a staple of modern agriculture and home gardening. Its active…

A former client was kind enough to write a summary of my handling of his defective hip case. I am grateful to this client for taking the time to write, and I have reproduced it below: My experience with Attorney Clay Hodges: background, our interaction, case outcome and my assessment  Having suffered from increasing discomfort…

In 2017, the U.S. Food and Drug Administration (FDA) approved dupilumab (which goes by the brand name Dupixent) as a treatment for atopic dermatitis (commonly known as eczema). However, recent research has identified a possible link between Dupixent and cutaneous T-cell lymphoma (CTCL), a type of cancer. If you have taken (or are taking) Dupixent,…

The Cartiva toe implant recall affected 6mm, 8mm, 10mm and 12mm sized implants distributed from July 2016 to October 2024. This amounted to a total recall and withdrawal of all Cartiva SCIs from the market.

When a person inhales respirable crystalline silica, or RCS, the particles get lodged into the lungs and cause inflammation and scarring. With enough exposure, it can cause death.

A study from 2021 looked at patients who took semaglutide medications like Ozempic to treat type 2 diabetes. They found that it increased the risk of DVT by 266%.

Cases involving individual plaintiffs allege Pfizer and related companies should have done more to warn users about the potential risks with MPA and/or investigate the possible link between brain tumors and Depo-Provera.

Zimmer Biomet initiated a voluntary recall of the Zimmer CPT Hip System to provide updated instructions on the risk of femur fracture. Zimmer Biomet also explained that they would stop selling this particular artificial hip by December 2024.

In the study, among the group with diabetes who received a NAION diagnosis, 8.9% of those took medication with semaglutide, while 1.8% took a different medication for their diabetes.